Benitec Biopharma approves $360k CEO bonus, $162k Exec Director bonus for FY2024

Benitec Biopharma Inc.

Compensation Committee approved discretionary bonus of $360,360 for CEO Jerel Banks for FY ending June 30, 2024.
Executive Director Megan Boston received a bonus of $161,580 (converted from AUD at ~0.67 USD/AUD).
Bonuses were approved on November 7, 2024, and reflect performance during fiscal year 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.